The methanol and ethanol solvates of 4-glutarato-N,N-diisopropyltryptamine
Maria Naeem, Barbara E. Bauer, Andrew R Chadeayne, James A. Golen, David R. Manke
Acta Crystallographica. Section E, Crystallographic Communications September 22, 2022 DOI: 10.1107/s2056989022009094 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Structural determination Peer reviewed |
|---|---|
| Key points | Both solvated forms of 4-glutarato-N,N-diisopropyltryptamine form near identical two-dimensional hydrogen-bonding networks parallel to the (100) plane. |
Abstract
The solid-state structures of two solvated forms of 4-glutarato- N , N -diisopropyltryptamine were determined by single-crystal X-ray diffraction, namely, 5-[(3-{2-[bis(propan-2-yl)azaniumyl]ethyl}-1 H -indol-4-yl)oxy]-5-oxopentanoate methanol monosolvate, C 21 H 30 N 2 O 4 ·CH 3 OH, and the analogous ethanol monosolvate, C 21 H 30 N 2 O 4 ·C 2 H 6 O. In both compounds, the 4-glutarato- N , N -diisopropyltryptamine exists as a zwitterion with a protonated tertiary ammonium and a deprotonated glutarato carboxylate. The tryptamine zwitterions and alcohol solvates in both structures combine to produce near identical hydrogen-bonding networks, with N—H...O and O—H...O hydrogen bonds joining the molecules together in two-dimensional networks parallel to the (100) plane.
Citations in the library
Cited by 3
- Bis(4-acetoxy-N-ethyl-N-n-propyltryptammonium) fumarate–fumaric acid (1/1) IUCrData September 7, 2023
- Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics. ACS Chemical Neuroscience June 17, 2026
- 4-Hydroxy-N,N-diisopropyltryptammonium hydrofumarate IUCrData June 1, 2025
Cites 17
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. European Neuropsychopharmacology May 20, 2016
- Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology May 1, 2020
- Reviewing the Potential of Psychedelics for the Treatment of PTSD The International Journal of Neuropsychopharmacology March 12, 2020
- Investigation of the Structure–Activity Relationships of Psilocybin Analogues ACS Pharmacology & Translational Science December 14, 2020
and 12 more in the library